‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long – The Washington Post

2 days ago

0 Views

1 Min Read

‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long The Washington Post
After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses NBC News
New drug nearly doubles survival rates in some pancreatic cancer patients, study says CBS News
Daily pill can double survival time for world’s deadliest cancer, trial shows The Guardian
ASCO: RevMed confident in Ras leadership as rivals square up Fierce Biotech